Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

668
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
668
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

602
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
602
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

512
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
512
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.2K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Telehealth Network of Minas Gerais, Brazil: two decades of scaling and sustainability.

BMJ global health·2026
Same author

Editorial: Imaging in glaucoma.

Frontiers in medicine·2026
Same author

Challenges in Diagnosis of Congenital Toxoplasmosis on Postimplementation of Minas Gerais Screening Program.

The Pediatric infectious disease journal·2025
Same author

Longitudinal Simulated Driving Performance and Rates of Progressive Visual Field Loss in Glaucoma.

Translational vision science & technology·2025
Same author

Cytotoxic Signature and IFN-γ Production Dominate CD4<sup>+</sup> T-Cell Response During Human Toxoplasmosis.

Immunology·2025
Same author

Enhancing Ophthalmic Triage: identification of new clinical features to support healthcare professionals in triage.

Eye (London, England)·2024

Related Experiment Video

Updated: Aug 8, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.4K

Glaucoma and Telemedicine.

Camilo Brandão-de-Resende1, Liliane de Abreu Rosa de Alcântara2, Daniel Vítor Vasconcelos-Santos2

  • 1Clinical Research Facility, Moorfields Eye Hospital, National Health Service Foundation Trust, London, UK.

Journal of Glaucoma
|February 27, 2023
PubMed
Summary
This summary is machine-generated.

Teleglaucoma, using telemedicine for glaucoma care, offers remote screening and monitoring. Further research and clearer regulations are needed to establish its global cost-effectiveness and safety.

More Related Videos

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Related Experiment Videos

Last Updated: Aug 8, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.4K
Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.7K

Area of Science:

  • Ophthalmology
  • Telemedicine
  • Digital Health

Background:

  • The COVID-19 pandemic accelerated the adoption of telemedicine for healthcare delivery.
  • Teleglaucoma applies telemedicine to screen and monitor glaucoma, an optic neuropathy.
  • It addresses distance barriers and improves access to eye care services.

Purpose of the Study:

  • To highlight the role of teleglaucoma in early glaucoma detection and remote patient management.
  • To discuss the potential of new technologies, including AI, in enhancing teleglaucoma accuracy.
  • To identify the need for regulatory clarity and robust data systems for teleglaucoma implementation.

Main Methods:

  • Utilizing telemedicine platforms for remote glaucoma screening and monitoring.
  • Implementing virtual clinics with synchronous data collection by non-specialists and asynchronous review by ophthalmologists.
  • Exploring the integration of artificial intelligence for improved diagnostic accuracy.

Main Results:

  • Teleglaucoma facilitates early disease detection, particularly in underserved areas.
  • Remote monitoring can optimize healthcare logistics, reduce consultations, and save costs for low-risk patients.
  • AI integration shows promise for enhancing accuracy and supporting clinical decisions.

Conclusions:

  • Teleglaucoma represents a significant advancement in managing glaucoma remotely.
  • Clearer regulatory frameworks and robust data infrastructure are essential for widespread adoption.
  • Continued studies are required to validate global cost-effectiveness and safety.